Cargando…

Oral administration of Lactobacillus paracasei NCC 2461 for the modulation of grass pollen allergic rhinitis: a randomized, placebo-controlled study during the pollen season

BACKGROUND: The efficacy of Lactobacillus paracasei NCC 2461 in modulating allergic rhinitis was previously evaluated in two exploratory clinical studies. Oral administration with NCC 2461 reduced specific subjective symptoms following nasal provocation tests with controlled grass pollen allergen co...

Descripción completa

Detalles Bibliográficos
Autores principales: Nembrini, Chiara, Singh, Anurag, De Castro, Carlos Antonio, Mercenier, Annick, Nutten, Sophie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4673783/
https://www.ncbi.nlm.nih.gov/pubmed/26664720
http://dx.doi.org/10.1186/s13601-015-0085-4
_version_ 1782404807558955008
author Nembrini, Chiara
Singh, Anurag
De Castro, Carlos Antonio
Mercenier, Annick
Nutten, Sophie
author_facet Nembrini, Chiara
Singh, Anurag
De Castro, Carlos Antonio
Mercenier, Annick
Nutten, Sophie
author_sort Nembrini, Chiara
collection PubMed
description BACKGROUND: The efficacy of Lactobacillus paracasei NCC 2461 in modulating allergic rhinitis was previously evaluated in two exploratory clinical studies. Oral administration with NCC 2461 reduced specific subjective symptoms following nasal provocation tests with controlled grass pollen allergen concentrations. Our aim was to confirm the anti-allergic effect of NCC 2461 in grass pollen allergic subjects exposed to natural doses of allergens during the pollen season. FINDINGS: A double-blind, randomized, placebo-controlled, parallel study was conducted with 131 grass pollen allergic subjects from May to July 2012 in concomitance with the pollen season in Berlin. NCC 2461 or placebo was administered daily for an 8-week period to adult subjects with clinical history of allergic rhinitis to grass pollen, positive skin prick test and IgE to grass pollen. During the 8 weeks, symptoms and quality of life questionnaires were filled out, and plasma was collected for IgE analysis at screening and at the end of the intervention. All subjects were included within a 5-day interval, ensuring exposure to similar air pollen counts for each individual during the trial period. The results obtained show that symptoms increased with pollen loads, confirming a natural exposure to the allergen and presence of pollen-induced allergic rhinitis in the subjects. However, no significant differences were observed in allergic rhinitis symptoms scores, quality of life, or specific IgE levels between subjects receiving NCC 2461 as compared to placebo administration. CONCLUSION: In contrast to previous findings, oral administration of NCC 2461 did not show a beneficial effect on allergic rhinitis in a field trial. The influence of study design, allergen exposure and intervention window on the efficacy of NCC 2461 in modulating respiratory allergy should be further evaluated. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13601-015-0085-4) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4673783
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-46737832015-12-10 Oral administration of Lactobacillus paracasei NCC 2461 for the modulation of grass pollen allergic rhinitis: a randomized, placebo-controlled study during the pollen season Nembrini, Chiara Singh, Anurag De Castro, Carlos Antonio Mercenier, Annick Nutten, Sophie Clin Transl Allergy Brief Communication BACKGROUND: The efficacy of Lactobacillus paracasei NCC 2461 in modulating allergic rhinitis was previously evaluated in two exploratory clinical studies. Oral administration with NCC 2461 reduced specific subjective symptoms following nasal provocation tests with controlled grass pollen allergen concentrations. Our aim was to confirm the anti-allergic effect of NCC 2461 in grass pollen allergic subjects exposed to natural doses of allergens during the pollen season. FINDINGS: A double-blind, randomized, placebo-controlled, parallel study was conducted with 131 grass pollen allergic subjects from May to July 2012 in concomitance with the pollen season in Berlin. NCC 2461 or placebo was administered daily for an 8-week period to adult subjects with clinical history of allergic rhinitis to grass pollen, positive skin prick test and IgE to grass pollen. During the 8 weeks, symptoms and quality of life questionnaires were filled out, and plasma was collected for IgE analysis at screening and at the end of the intervention. All subjects were included within a 5-day interval, ensuring exposure to similar air pollen counts for each individual during the trial period. The results obtained show that symptoms increased with pollen loads, confirming a natural exposure to the allergen and presence of pollen-induced allergic rhinitis in the subjects. However, no significant differences were observed in allergic rhinitis symptoms scores, quality of life, or specific IgE levels between subjects receiving NCC 2461 as compared to placebo administration. CONCLUSION: In contrast to previous findings, oral administration of NCC 2461 did not show a beneficial effect on allergic rhinitis in a field trial. The influence of study design, allergen exposure and intervention window on the efficacy of NCC 2461 in modulating respiratory allergy should be further evaluated. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13601-015-0085-4) contains supplementary material, which is available to authorized users. BioMed Central 2015-12-09 /pmc/articles/PMC4673783/ /pubmed/26664720 http://dx.doi.org/10.1186/s13601-015-0085-4 Text en © Nembrini et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Brief Communication
Nembrini, Chiara
Singh, Anurag
De Castro, Carlos Antonio
Mercenier, Annick
Nutten, Sophie
Oral administration of Lactobacillus paracasei NCC 2461 for the modulation of grass pollen allergic rhinitis: a randomized, placebo-controlled study during the pollen season
title Oral administration of Lactobacillus paracasei NCC 2461 for the modulation of grass pollen allergic rhinitis: a randomized, placebo-controlled study during the pollen season
title_full Oral administration of Lactobacillus paracasei NCC 2461 for the modulation of grass pollen allergic rhinitis: a randomized, placebo-controlled study during the pollen season
title_fullStr Oral administration of Lactobacillus paracasei NCC 2461 for the modulation of grass pollen allergic rhinitis: a randomized, placebo-controlled study during the pollen season
title_full_unstemmed Oral administration of Lactobacillus paracasei NCC 2461 for the modulation of grass pollen allergic rhinitis: a randomized, placebo-controlled study during the pollen season
title_short Oral administration of Lactobacillus paracasei NCC 2461 for the modulation of grass pollen allergic rhinitis: a randomized, placebo-controlled study during the pollen season
title_sort oral administration of lactobacillus paracasei ncc 2461 for the modulation of grass pollen allergic rhinitis: a randomized, placebo-controlled study during the pollen season
topic Brief Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4673783/
https://www.ncbi.nlm.nih.gov/pubmed/26664720
http://dx.doi.org/10.1186/s13601-015-0085-4
work_keys_str_mv AT nembrinichiara oraladministrationoflactobacillusparacaseincc2461forthemodulationofgrasspollenallergicrhinitisarandomizedplacebocontrolledstudyduringthepollenseason
AT singhanurag oraladministrationoflactobacillusparacaseincc2461forthemodulationofgrasspollenallergicrhinitisarandomizedplacebocontrolledstudyduringthepollenseason
AT decastrocarlosantonio oraladministrationoflactobacillusparacaseincc2461forthemodulationofgrasspollenallergicrhinitisarandomizedplacebocontrolledstudyduringthepollenseason
AT mercenierannick oraladministrationoflactobacillusparacaseincc2461forthemodulationofgrasspollenallergicrhinitisarandomizedplacebocontrolledstudyduringthepollenseason
AT nuttensophie oraladministrationoflactobacillusparacaseincc2461forthemodulationofgrasspollenallergicrhinitisarandomizedplacebocontrolledstudyduringthepollenseason